US112966A
(en)
*
|
|
1871-03-21 |
|
Improvement in hay and cotton-presses |
US3817978A
(en)
|
1971-06-16 |
1974-06-18 |
Syntex Inc |
4-fluoro nucleosides and sugar intermediates, and methods of preparing
|
US3852267A
(en)
|
1972-08-04 |
1974-12-03 |
Icn Pharmaceuticals |
Phosphoramidates of 3{40 ,5{40 -cyclic purine nucleotides
|
US4713383A
(en)
|
1984-10-01 |
1987-12-15 |
Ciba-Geigy Corporation |
Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
|
US5679342A
(en)
|
1987-11-18 |
1997-10-21 |
Chiron Corporation |
Hepatitis C virus infected cell systems
|
US5714596A
(en)
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US5698390A
(en)
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
IN167775B
(es)
|
1988-06-24 |
1990-12-22 |
Hoechst India |
|
US6027729A
(en)
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
DE3932052A1
(de)
|
1989-09-26 |
1991-04-04 |
Basf Ag |
Oxazol- bzw. thiazolcarbonsaeureamide
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
JP2889408B2
(ja)
|
1991-09-17 |
1999-05-10 |
富士写真フイルム株式会社 |
アゾメチン化合物及びこれを含有する熱転写色素供与材料
|
GB9202791D0
(en)
|
1992-02-11 |
1992-03-25 |
British Bio Technology |
Compounds
|
AU729657B2
(en)
|
1992-05-11 |
2001-02-08 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting viral replication
|
DE4232852A1
(de)
|
1992-09-30 |
1994-03-31 |
Bayer Ag |
Imidazolinyl-pyridazine
|
ZA943999B
(en)
|
1993-06-09 |
1995-02-03 |
Lonza Ag |
Quaternary ammonium and waterproofing/preservative compositions
|
WO1995008540A1
(en)
|
1993-09-22 |
1995-03-30 |
The Wellcome Foundation Limited |
Bis(amidinobenzimidazolyl)alkanes as antiviral agents
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
CZ293584B6
(cs)
|
1996-01-23 |
2004-06-16 |
Icn Pharmaceuticals |
Prostředek pro modulaci exprese lymfokinů
|
ATE271063T1
(de)
|
1996-10-16 |
2004-07-15 |
Icn Pharmaceuticals |
Purin-l-nukleoside, deren analoga und verwendungen
|
IL129126A0
(en)
|
1996-10-16 |
2000-02-17 |
Icn Pharmaceuticals |
Monocyclic l-nucleosides analogs and uses thereof
|
EP2341058A3
(en)
|
1997-09-12 |
2011-11-23 |
Exiqon A/S |
Oligonucleotide Analogues
|
BR9908270A
(pt)
|
1998-02-25 |
2004-06-29 |
Univ Emory |
2-fluoro-nucleosìdeos, composições farmacêuticas e seus usos
|
US20030203862A1
(en)
|
1998-03-26 |
2003-10-30 |
Miraglia Loren J. |
Antisense modulation of MDM2 expression
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
PT1178999E
(pt)
|
1999-05-04 |
2007-06-26 |
Santaris Pharma As |
Análogos de l-ribo-lna
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
NZ547204A
(en)
|
2000-05-26 |
2008-01-31 |
Idenix Cayman Ltd |
Methods and compositions for treating flaviviruses and pestiviruses
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
GB0019124D0
(en)
|
2000-08-03 |
2000-09-27 |
Pfizer |
Novel process
|
CN1646141B
(zh)
|
2000-10-18 |
2014-06-25 |
吉利德制药有限责任公司 |
用于治疗病毒感染和异常细胞增殖的修饰核苷类化合物
|
MXPA03006514A
(es)
|
2001-01-22 |
2004-12-02 |
Merck & Co Inc |
Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico.
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
WO2003026675A1
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
AU2002330154A1
(en)
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
AT411065B
(de)
|
2001-12-27 |
2003-09-25 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von heterocyclischen (r)- und (s)-cyanhydrinen
|
CA2474563C
(en)
|
2002-02-13 |
2010-11-09 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
US20120041184A1
(en)
|
2002-02-20 |
2012-02-16 |
Leonid Beigelman |
RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
CA2477795A1
(en)
|
2002-02-28 |
2003-09-12 |
Kandasamy Sakthivel |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
AU2003269892A1
(en)
|
2002-06-27 |
2004-01-19 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
WO2004002999A2
(en)
|
2002-06-28 |
2004-01-08 |
Idenix (Cayman) Limited |
Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
AU2003269902A1
(en)
|
2002-07-16 |
2004-02-02 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
WO2004080466A1
(en)
|
2003-03-07 |
2004-09-23 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
CN1774425A
(zh)
|
2003-04-16 |
2006-05-17 |
霍夫曼-拉罗奇有限公司 |
喹唑啉化合物
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
*
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
CA2734052A1
(en)
*
|
2003-05-30 |
2005-01-13 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
WO2005007810A2
(en)
|
2003-06-16 |
2005-01-27 |
Grinstaff Mark W |
Functional synthetic molecules and macromolecules for gene delivery
|
PL1658302T3
(pl)
|
2003-07-25 |
2011-03-31 |
Idenix Pharmaceuticals Inc |
Analogi nukleozydów purynowych do leczenia chorób spowodowanych przez Flaviviridae obejmujących zapalenie wątroby typu C
|
MXPA06002198A
(es)
|
2003-08-27 |
2007-08-14 |
Biota Scient Management |
Nucleosidos o nucleotidos triciclicos novedosos como agentes terapeuticos.
|
US20080234498A1
(en)
|
2003-10-08 |
2008-09-25 |
President And Fellow Of Harvard College |
Pyrovalerone Analogues and Therapeutic Uses Thereof
|
CA2571675A1
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
US20070265222A1
(en)
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
CA2600359A1
(en)
|
2005-03-09 |
2006-09-09 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
US20060229265A1
(en)
|
2005-03-30 |
2006-10-12 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
CA2609342A1
(en)
|
2005-04-26 |
2006-11-02 |
Andrei L. Gartel |
Nucleoside compounds and methods of use thereof
|
CN101287472B
(zh)
|
2005-08-15 |
2011-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
|
JP2009532448A
(ja)
|
2006-04-03 |
2009-09-10 |
アストラゼネカ アクチボラグ |
置換アデニンおよびそれらの使用
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
AP2009004812A0
(en)
*
|
2006-10-10 |
2009-04-30 |
Medivir Ab |
HCV nucleoside inhibitor
|
WO2008089439A2
(en)
|
2007-01-18 |
2008-07-24 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
AU2008210411A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5A derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
WO2008127613A1
(en)
|
2007-04-11 |
2008-10-23 |
Scynexis, Inc. |
New pharmaceutical compositions
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
SI2014771T1
(sl)
|
2007-06-25 |
2015-04-30 |
Anadys Pharmaceuticals, Inc. |
Kontinuiran postopek encimske hidrolize
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
EP2019100A1
(en)
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
US20090076062A1
(en)
|
2007-09-13 |
2009-03-19 |
Juergen Klaus Maibaum |
Organic Compounds
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
WO2009058800A2
(en)
|
2007-10-29 |
2009-05-07 |
President And Fellows Of Harvard College |
Synthesis of nucleosides
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US8293720B2
(en)
|
2007-12-20 |
2012-10-23 |
Dogwood Pharmaceuticals, Inc. |
Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
ATE551342T1
(de)
|
2008-02-22 |
2012-04-15 |
Irm Llc |
Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
|
EP3042660A3
(en)
|
2008-04-15 |
2016-10-26 |
RFS Pharma, LLC. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
WO2010002877A2
(en)
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
EP2332953A1
(en)
|
2008-09-05 |
2011-06-15 |
Kotobuki Pharmaceutical Co., Ltd. |
Substituted amine derivative and medicinal composition comprising same as the active ingredient
|
TW201023858A
(en)
|
2008-09-18 |
2010-07-01 |
Ortho Mcneil Janssen Pharm |
Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
|
EA201100851A1
(ru)
|
2008-12-23 |
2012-04-30 |
Фармассет, Инк. |
Аналоги нуклеозидов
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
WO2010091386A2
(en)
|
2009-02-06 |
2010-08-12 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
WO2010108135A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
KR20110128947A
(ko)
|
2009-03-20 |
2011-11-30 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오시드 및 뉴클레오티드 유사체
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
US8552021B2
(en)
*
|
2009-09-29 |
2013-10-08 |
Janssen Products, L.P. |
Phosphoramidate derivatives of nucleosides
|
US20150018301A1
(en)
|
2009-11-06 |
2015-01-15 |
The Johns Hopkins University |
LRRK-2-Mediated Neuronal Toxicity
|
WO2011119869A1
(en)
|
2010-03-24 |
2011-09-29 |
Medical University Of South Carolina |
Compositions and methods for the treatment of degenerative diseases
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
FR2960235B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
|
FR2960234B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
|
BR112013001267A2
(pt)
|
2010-07-19 |
2016-05-17 |
Gilead Sciences Inc |
métodos para a preparação de pró-fármacos de fosforamidato diasteromericamente puro
|
SG186830A1
(en)
|
2010-07-22 |
2013-02-28 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
WO2012016713A1
(en)
|
2010-08-05 |
2012-02-09 |
Ruprecht-Karls-Universität Heidelberg |
Tumour targeting with polypeptides
|
WO2012025857A1
(en)
|
2010-08-23 |
2012-03-01 |
Hetero Research Foundation |
Cycloalkyl methoxybenzyl phenyl pyran derivatives as sodium dependent glucose co transporter (sglt2) inhibitors
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
PE20140608A1
(es)
|
2010-09-22 |
2014-06-12 |
Alios Biopharma Inc |
Analogos de nucleotidos sustituidos
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
WO2012041965A1
(en)
|
2010-09-29 |
2012-04-05 |
Universidad Nacional De Quilmes |
Process for producing dialkylphosphotriesters of nucleosides by enzymatic transesterification and deprotection thereof for producing nucleoside monophosphates
|
US20120082795A1
(en)
|
2010-10-01 |
2012-04-05 |
Ppg Industries Ohio, Inc. |
Method for using a primer comprising a self-emulsified polyester microgel
|
US9505798B2
(en)
|
2010-11-29 |
2016-11-29 |
New York University |
Steroid compounds as RORyt modulators and uses thereof
|
AU2011349278C1
(en)
|
2010-12-22 |
2017-01-19 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
US9095599B2
(en)
|
2011-01-03 |
2015-08-04 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
US9289445B2
(en)
|
2011-01-20 |
2016-03-22 |
University Of Rochester |
Compositions and methods for treating or preventing a retrovirus infection
|
WO2012161799A1
(en)
|
2011-02-24 |
2012-11-29 |
Georgia Health Sciences University Research Institute, Inc |
Epidithiodioxopiperazines and uses thereof in treating cancer
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
US8877733B2
(en)
|
2011-04-13 |
2014-11-04 |
Gilead Sciences, Inc. |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
WO2012167133A2
(en)
|
2011-06-01 |
2012-12-06 |
The Regents Of The University Of California |
Inhibitors of anandamide transport and their therapeutic uses
|
FR2977586B1
(fr)
|
2011-07-08 |
2013-07-12 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
DE102011108874A1
(de)
|
2011-07-28 |
2013-01-31 |
Hydac System Gmbh |
Steuervorrichtung
|
AU2012290089B2
(en)
|
2011-08-01 |
2016-09-29 |
Mbc Pharma, Inc. |
Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
WO2013044030A1
(en)
|
2011-09-23 |
2013-03-28 |
Enanta Pharmaceuticals, Inc. |
2'-chloroacetylenyl substituted nucleoside derivatives
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
FR2982858B1
(fr)
|
2011-11-18 |
2013-11-29 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
FR2984322B1
(fr)
|
2011-12-16 |
2013-12-20 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
ES2636448T3
(es)
*
|
2011-12-20 |
2017-10-05 |
Riboscience Llc |
Derivados de nucleósido 2',4'-difluoro-2'-metil sustituidos como inhibidores de la replicación del ARN del VHC
|
PL2794627T3
(pl)
|
2011-12-22 |
2019-04-30 |
Alios Biopharma Inc |
Podstawione nukleozydy, nukleotydy i ich analogi
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
WO2013138210A1
(en)
|
2012-03-14 |
2013-09-19 |
Ning Xi |
Substituted cyclic compounds and methods of use
|
NZ629428A
(en)
|
2012-03-21 |
2016-10-28 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
NZ631601A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
NZ630800A
(en)
|
2012-03-21 |
2016-06-24 |
Alios Biopharma Inc |
Methods of preparing substituted nucleotide analogs
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9809616B2
(en)
|
2012-10-29 |
2017-11-07 |
Emory University |
Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
AP3913A
(en)
|
2012-05-22 |
2016-11-26 |
Idenix Pharamaceuticals Inc |
D-amino acid compounds for liver disease
|
EP2676987A1
(en)
|
2012-06-21 |
2013-12-25 |
Universidad De Burgos |
Cross-linked aramid
|
EP2870169A1
(en)
|
2012-07-03 |
2015-05-13 |
Bristol-Myers Squibb Company |
Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
SG11201501036RA
(en)
|
2012-08-23 |
2015-03-30 |
Alios Biopharma Inc |
Compounds for the treatment of paramoxyvirus viral infections
|
WO2014047117A1
(en)
|
2012-09-18 |
2014-03-27 |
Bristol-Myers Squibb Company |
Process for preparing phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
SG11201502120XA
(en)
|
2012-09-26 |
2015-04-29 |
Merck Patent Gmbh |
Quinazolinone derivatives as parp inhibitors
|
DK2900657T3
(da)
|
2012-09-26 |
2020-05-04 |
Hoffmann La Roche |
Cykliske etherpyrazol-4-yl-heterocyclyl-carboxamidforbindelser og fremgangsmåder til anvendelse
|
EP2935304A1
(en)
*
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
RU2015120478A
(ru)
|
2012-12-20 |
2017-01-25 |
Альдейра Терапьютикс, Инк. |
Пери-карбинолы
|
FR3000065A1
(fr)
|
2012-12-21 |
2014-06-27 |
Univ Lille Ii Droit & Sante |
Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CN104870009B
(zh)
|
2012-12-21 |
2021-05-18 |
赛诺菲 |
官能化的毒蜥外泌肽-4衍生物
|
KR102327888B1
(ko)
|
2012-12-21 |
2021-11-17 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
|
JP6678455B2
(ja)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
Prmt5阻害剤およびその使用
|
MX358684B
(es)
|
2012-12-21 |
2018-08-31 |
Hoffmann La Roche |
Peptidos como agonistas de oxitocina.
|
SG11201504946VA
(en)
|
2012-12-21 |
2015-07-30 |
Quanticel Pharmaceuticals Inc |
Histone demethylase inhibitors
|
UA111305C2
(uk)
|
2012-12-21 |
2016-04-11 |
Пфайзер Інк. |
Конденсовані лактами арилу та гетероарилу
|
HUE036739T2
(hu)
|
2012-12-21 |
2018-07-30 |
Plexxikon Inc |
Vegyületek és eljárások kináz modulációra, és azok indikációi
|
LU92126B1
(fr)
|
2012-12-31 |
2014-07-01 |
Cesa Alliance Sa |
Composé pharmaceutique pour la prévention et le traitement d'un trouble ou d'une maladie de la mémoire, neurodégénérative ou neuronale
|
TW201526899A
(zh)
|
2013-02-28 |
2015-07-16 |
Alios Biopharma Inc |
醫藥組成物
|
ES2616508T3
(es)
*
|
2013-03-04 |
2017-06-13 |
Bayer Cropscience Aktiengesellschaft |
Derivados de 1H-pirazol sustituidos con halógeno como insecticidas
|
US20140309413A1
(en)
|
2013-03-11 |
2014-10-16 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
TW201532606A
(zh)
|
2013-04-05 |
2015-09-01 |
Alios Biopharma Inc |
使用化合物之組合治療c型肝炎病毒感染
|
WO2014186637A1
(en)
*
|
2013-05-16 |
2014-11-20 |
Riboscience Llc |
4'-fluor0-2'-methyl substituted nucleoside derivatives
|
DK3013843T3
(en)
|
2013-06-26 |
2018-09-03 |
Alios Biopharma Inc |
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
|
EP3013340B9
(en)
|
2013-06-26 |
2023-10-04 |
Janssen Pharmaceuticals, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
BR112016003348B1
(pt)
|
2013-08-21 |
2023-03-07 |
Alios Biopharma, Inc |
Compostos antivirais ou sais farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e seus usos
|
DK3030549T3
(da)
|
2013-09-12 |
2019-05-13 |
Janssen Biopharma Inc |
Pyridazinonforbindelser og anvendelser deraf
|
PE20160661A1
(es)
|
2013-09-12 |
2016-08-05 |
Alios Biopharma Inc |
Compuesto de azapiridona y sus usos de los mismos
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
AU2015280234B2
(en)
|
2014-06-24 |
2021-04-01 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
HUE051986T2
(hu)
*
|
2014-06-24 |
2021-04-28 |
Janssen Biopharma Inc |
Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra
|
RU2017105470A
(ru)
|
2014-07-22 |
2018-08-22 |
Элиос Биофарма, Инк. |
Способы лечения парамиксовирусов
|
US20160045528A1
(en)
|
2014-08-05 |
2016-02-18 |
Alios Biopharma, Inc. |
Combination therapy for treating a paramyxovirus
|
US9908914B2
(en)
|
2014-10-28 |
2018-03-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41614A
(fr)
|
2015-02-25 |
2018-01-02 |
Alios Biopharma Inc |
Composés antiviraux
|
EP3268368A4
(en)
|
2015-03-11 |
2018-11-14 |
Alios Biopharma, Inc. |
Aza-pyridone compounds and uses thereof
|
JP6860585B2
(ja)
|
2016-03-09 |
2021-04-14 |
ヤンセン バイオファーマ インク. |
非環状抗ウイルス 優先出願の参照による組み込み
|
US10183945B2
(en)
|
2016-03-10 |
2019-01-22 |
Alios Biopharma, Inc. |
Method of preparing AZA-pyridone compounds
|
WO2017223231A1
(en)
|
2016-06-21 |
2017-12-28 |
Alios Biopharma, Inc. |
(s)-8-(benzhydryl )-6-isopropyl-3,5-dioxo- 5, 6,7,8,-tetrahydro-3h-pyrazino-[1,2-b]pyridazin-yl-isobutyrate antiviral agent for use in treating influenza
|
US20180117042A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|
WO2018222774A1
(en)
|
2017-05-30 |
2018-12-06 |
Alios Biopharma, Inc. |
Methods for treating pneumoviruses
|
WO2020121122A1
(en)
|
2018-12-12 |
2020-06-18 |
Janssen Biopharma, Inc. |
Cyclobutyl nucleoside analogs as anti-virals
|
MX2021006993A
(es)
|
2018-12-12 |
2021-10-22 |
Janssen Biopharma Inc |
Analogos de nucleosidos de ciclopentilo como antivirales.
|